Modifying Antiretroviral Therapy in Virologically Suppressed HIV-Infected Patients
Summary
- Several trials have been undertaken to address the safety and efficacy of modifying NNRTI-based regimens to both 3-drug dolutegravir-based regimens and 2-drug INSTI regimens
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content